John A. Lincoln, M.D., Ph.D.
Assistant Professor of Neurology
- Patient Appointments: 832-325-7080
- Assistant: 713-500-7029
- Fax: 713-500-7040
- E-mail: John.A.Lincoln@uth.tmc.edu
Education and Training
- B.S., Texas A&M University, College Station, Texas
- M.S., Ph.D., Texas Tech University, Lubbock, Texas
- M.D., Texas Tech University Health Sciences Center, Lubbock, Texas
- Internship, Texas Tech University Health Sciences Center, Lubbock Texas
- Neurology Residency, The University of Texas Health Science Center at Houston, Houston, Texas
- Research and Clinical Neuroimmunology Fellowship, University of Medicine and Dentistry of New Jersey, Newark, New Jersey
- American Board of Psychiatry and Neurology in Neurology
- Multiple Sclerosis (MS)
- Immune-mediated Neurological Disorders
- Neurodegenerative processes in MS
- Magnetic Resonance Imaging in MS
John A. Lincoln, M.D., Ph.D., recently joined the Multiple Sclerosis research group at UTHealth. He is also involved with the Magnetic Resonance Imaging Analysis Center at the Medical School.
Dr. Lincoln graduated in 1992 from Texas A&M University with a Bachelor of Science degree in Genetics. By 1998, he obtained a Masterís degree in Microbiology and a Doctorate of Philosophy in Immunology from Texas Tech University, where his research focused on the role of macrophages in innate immunity. He obtained his Doctorate of Medicine in 2002 from Texas Tech University Health Sciences Center and completed an Internal Medicine internship. Following a residency in Neurology at The University of Texas Health Science Center at Houston, Dr. Lincoln completed a Neuroimmunology fellowship at the University of Medicine and Dentistry of New Jersey (UMDNJ). In 2008 he joined the faculty at UMDNJ as both a clinician and researcher. While in Newark, his research focused on the potential viral etiologies of Multiple Sclerosis (MS) and in evaluating a new animal model of virally-mediated demyelination.
Dr. Lincoln has published articles related to the etiology, immunology, and clinical profiles seen in MS and is currently interested in evaluating the role of neurodegeneration in disease.